Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by mR Ganta
The Promising Role of Pembrolizumab in the Management of Patients With Pd-L1-Positive Non-Small Cell Lung Cancer: A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Comparison of the Toxicity Profile of PD-1 Versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Analysis of the Literature
Cancer
Cancer Research
Oncology
PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion
PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer
Medicinski podmladak
Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
The Use of Systemic Treatment in the Maintenance of Patients With Non–Small Cell Lung Cancer: A Systematic Review
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cn5 - Cost-Effectiveness of Pembrolizumab Versus Standard-Of-Care Chemotherapies for First-Line Treatment of Pd-L1 Positive (≥50%) Metastatic Non-Small Cell Lung Cancer in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
